Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1986-04-29
1988-12-06
Warden, Robert J.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 514 25, A61K 4300, A61K 4900
Patent
active
047895420
ABSTRACT:
A radioiodinated branched carbohydrate for tissue imaging. Iodine-123 is stabilized in the compound by attaching it to a vinyl functional group that is on the carbohydrate. The compound exhibits good uptake and retention and is promising in the development of radiopharmaceuticals for brain, heart and tumor imaging.
REFERENCES:
"Nuclear Medicine Progress Report for Quarter Ending Jun. 30, 1985" (ORNL/TM-9707) Knapp, Ambrose, Goodman, Srivastava.
"Nuclear Medicine Progress Report for Quarter Ending Dec. 31, 1984" (ORNL/TM-9480) Knapp, Ambrose, Goodman, Srivastava.
Abstract submitted to Society of Nuclear Medicine for 33rd Annual Meeting Jun. 22-25, 1986, Washington, D.C.
Goodman Mark M.
Knapp, Jr. Furn F.
Hamel Stephen D.
Hightower Judson R.
Lovingood Katherine P.
The United States of America as represented by the United States
Warden Robert J.
LandOfFree
Radioiodinated glucose analogues for use as imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioiodinated glucose analogues for use as imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioiodinated glucose analogues for use as imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1493265